
FDA scales back food facility inspections in face of coronavirus
FDA says it will now only send inspectors out to domestic facilities for “mission-critical” purposes, such as “public health emergencies involving FDA-regulated products.”
The U.S. Food and Drug Administration announced yesterday that it is “scaling back” on
FDA typically conducts risk-analysis inspections at facilities every few years. FDA says it will now only send inspectors out to domestic facilities for “mission-critical” purposes, such as “public health emergencies involving FDA-regulated products.” Many of FDA’s staff is already teleworking, excluding those engaged in activities such as lab-related activities or monitoring imported products.
The agency is also evaluating how it can conduct regulatory actions in the meantime. It said yesterday: “Importantly, during this interim period we’re evaluating additional ways to conduct our inspectional work that would not jeopardize public safety and protecting both the firms and the FDA staff. This can include, among other things, evaluating records in lieu of conducting an onsite inspection on an interim basis when travel is not permissible, when appropriate.” The agency urged companies to adhere to good manufacturing practices, noting that in the last fiscal year, the violation rate domestically was “only about 5%.”
In a
Nutritional Outlook thanks the American Herbal Products Association for the tip.
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.





